Meghan Pinezich

Meghan is a Postdoctoral Scientist in the Laboratory for Stem Cells and Tissue Engineering at Columbia University. Her research focuses on lung bioengineering at multiple scales, including whole lung regeneration using bioreactors, implantable biomaterials for localized treatment of lung injury, and molecular analysis of the extracellular matrix in cystic fibrosis. Meghan also leads the Columbia Biomedical Engineering Technology Accelerator (BiomedX) where she has served as Program Manager since 2020. In her role at BiomedX, Meghan has managed a total investment of over $1M in early-stage medical device teams, leading to the launch of multiple start-up’s during her tenure. She has co-authored over 17 peer-reviewed publications and is a co-inventor of multiple technologies with one issued and several pending patents.